title: Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats.
abstract: Ghrelin, a gut-brain peptide, is best known for its role in the stimulation of feeding and growth hormone release. In the brain, orexin, neuropeptide Y (NPY), and ghrelin are parts of a food intake regulatory circuit. Orexin and NPY are also implicated in maintaining wakefulness. Previous experiments in our laboratory revealed that intracerebroventricular injections of ghrelin induce wakefulness in rats. To further elucidate the possible role of ghrelin in the regulation of arousal, we studied the effects of microinjections of ghrelin into hypothalamic sites, which are implicated in the regulation of feeding and sleep, such as the lateral hypothalamus (LH), medial preoptic area (MPA), and paraventricular nucleus (PVN) on sleep in rats. Sleep responses, motor activity, and food intake after central administration of 0.04, 0.2, or 1 mug (12, 60, or 300 pmol) ghrelin were recorded. Microinjections of ghrelin into the LH had strong wakefulness-promoting effects lasting for 2 h. Wakefulness was also stimulated by ghrelin injection into the MPA and PVN; the effects were confined to the first hour after the injection. Ghrelin's non-rapid-eye-movement sleep-suppressive effect was accompanied by attenuation in the electroencephalographic (EEG) slow-wave activity and changes in the EEG power spectrum. Food consumption was significantly stimulated after microinjections of ghrelin into each hypothalamic site. Together, these results are consistent with the hypothesis that forebrain ghrelinergic mechanisms play a role in the regulation of vigilance, possibly through activating the components of the food intake- and arousal-promoting network formed by orexin and NPY.
authors.affiliation: Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Neuroscience Program, Washington State University, Pullman, Washington, WA 99164-6520, USA.
authors.forename: Eva
authors.initials: E
authors.lastname: Szentirmai
authors.forename: Levente
authors.initials: L
authors.lastname: Kapás
authors.forename: James M
authors.initials: JM
authors.lastname: Krueger
mesh_terms: D000818:Animals; D004569:Electroencephalography; D004576:Electromyography; D005247:Feeding Behavior / Q000187:drug effects*; D054439:Ghrelin; D007026:Hypothalamic Area, Lateral; D008297:Male; D008845:Microinjections; D010286:Paraventricular Hypothalamic Nucleus; D036361:Peptide Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D011301:Preoptic Area; D016548:Prosencephalon / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012890:Sleep / Q000187:drug effects; D012894:Sleep Stages / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects; D014851:Wakefulness / Q000187:drug effects*
chemical_list: D054439:Ghrelin; D036361:Peptide Hormones